General Information
Revision date
2015-10-19
Product name
Methylphenidate HCl Tablets USP 5, 10 mg and 20 mg
Product Synonyms
Methylphenidate HCl Tablets
Chemical name
2-Piperidineacetic acid, α-phenyl-, methyl ester, hydrochloride
CAS No.
298-59-9
1.2.1 Relevant identified uses
and weight C14H19NO2 ⋅ HCl
Emergency telephone
Ascent Pharmaceuticals Inc
Icons in SDS
Company Information
company name
Ascent Pharmaceuticals Inc
Section 2
SECTION 2: Hazards identification
OSHA EMERGENCY OVERVIEW Caution Statement: May be fatal if swallowed. Harmful if inhaled or absorbed through skin. Allergen. Exposure may produce allergic response. Affects central nervous system. Read package insert prior to use.
Principle Routes of Exposure
Ingestion, Skin contact Eyes: May cause irritation. Skin Contact: with skin may cause irritation. Allergic reactions are possible, Rash. Inhalation: Narcotic. Can irritate the respiratory passages and cause sneezing, coughing, hypersensitivity. Other symptoms will parallel ingestion. Ingestion: Narcotic. Toxic if swallowed. Ingestion may cause gastrointestinal irritation, nausea, vomiting and diarrhea. Ingestion of this product may result in central nervous system stimulation including muscle twitching, generalized weakness, difficulty breathing and coma. May cause headaches and dizziness, Anxiety, Tachycardia, (excessively rapid heartbeat, including rapid and weak pulse).Hypertension (high blood pressure), Mental impairment, Confusion, agitation and/or excitation, Tremors, convulsions, Fever, Dryness of mouth and throat. Effects of Overexposure: Symptoms of overdose include agitation, confusion, convulsions possibly followed by coma. Chronic exposure: Hypersensitivity, May cause habituation or addiction. Carcinogenicity: - Not listed by IARC, NTP and OSHA.
